Mirae Asset Global Investments
TPTX

Mirae Asset Global Investments’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Mirae Asset Global Investments’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,955
Closed -$1.13M – 2711
2022
Q2 		$1.13M Buy
+14,955
New +$665K ﹤0.01% 1351
2022
Q1 		– Sell
-25,072
Closed -$1.2M – 1667
2021
Q4 		$1.2M Buy
25,072
+9,586
+62% +$429K ﹤0.01% 1250
2021
Q3 		$1.03M Buy
15,486
+761
+5% +$54.2K ﹤0.01% 1286
2021
Q2 		$1.15M Buy
14,725
+4,764
+48% +$352K ﹤0.01% 1207
2021
Q1 		$942K Buy
+9,961
New +$1.18M ﹤0.01% 1147

Mirae Asset Global Investments's TPTX Position: Q3 2022 in Review

Mirae Asset Global Investments sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 14,955 shares — an estimated $1.13M sold.

Mirae Asset Global Investments first reported a position in TPTX in Q1 2021 and held it in 5 quarters. The position peaked at $1.2M in Q4 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Mirae Asset Global Investments reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 14,955 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.13M.
  • Mirae Asset Global Investments first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Mirae Asset Global Investments's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.2M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Mirae Asset Global Investments's 13F filing for Q3 2022, filed 10 Nov 2022.